Stamboulian
Stamboulian is an Argentine private healthcare services company providing vaccination, clinical laboratory diagnostics, and infectious disease medical care across 11+ owned centers in the Buenos Aires metropolitan area, serving more than 450,000 patients per year through insurance billing and direct payments.
- Company typePrivate
- Founded1981
- HeadquartersTandil, Argentina
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Stamboulian does
Stamboulian Servicios de Salud (legal entity STAMBOULIAN SERVICIOS DE SALUD – C.E.I. S.A.) is an Argentine private healthcare services company specializing in infectious disease prevention, diagnosis, and treatment. Founded by Dr. Daniel Stamboulian and headquartered in Argentina, the company operates a network of 11+ owned vaccination centers and clinical laboratories across the Buenos Aires metropolitan area, including Abasto, Barrio Norte, Belgrano, El Solar, San Isidro, Vicente López, Flores, Villa Urquiza, Microcentro, and Villa Crespo, serving more than 450,000 patients per year. Its core product lines are Servicio Vacunas (routine, travel, HPV, dengue, flu, and specialty vaccines), Servicio Laboratorio (clinical reference laboratory with COVID-19 RT-PCR and rapid antigen testing, molecular HPV detection and genotyping, and general diagnostics supported by a processing plant), Atención Médica (infectious disease and traveler medicine consultations), and a food and environmental safety division offering audits, training, and microbiological testing for businesses.
The underlying technology centers on conventional laboratory diagnostic methods (molecular biology, microbiology) rather than software platforms, with patient-facing digital tools limited to online appointment booking, medical order submission, a vaccine and lab test search tool, and the Portal LAB client portal for registered healthcare professional clients. The business model is professional services plus fee-for-service healthcare delivery: revenue is generated from direct patient payments and from billing to Obras Sociales (Argentine social health insurance) and Prepagas (private health plans) for vaccines, laboratory studies, and consultations. Customer segments span all age groups for routine vaccination, plus targeted segments for women (HPV and reproductive health), travelers (yellow fever and pre-travel consultations), adolescents and young adults, adults 50+ and seniors, and a smaller B2B stream in food and environmental safety.
Beyond clinical services, Stamboulian runs an institutional health-education magazine (Revista Reflexiones) and a WhatsApp community channel, and maintains a Clinical Trials business unit supporting vaccine and pharmaceutical research. The company is privately held, headquartered in Argentina, and compliant with Argentina's Law 25.326 on Personal Data Protection. Strategic activity in 2024–2026 has centered on adding new centers (Vicente López, 2025), extending service hours (weekend and holiday operations at Flores and Villa Urquiza, 2024), and broadening the medical consultation portfolio with an Andrology service (2025), consistent with an organic, multi-site expansion model in the Buenos Aires metro.
Stamboulian firmographics
Firmographics- Name
- Stamboulian
- Legal name
- STAMBOULIAN SERVICIOS DE SALUD -C.E.I. S.A.-
- Website
- https://stamboulian.com.ar
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Stamboulian is an Argentine private healthcare services company providing vaccination, clinical laboratory diagnostics, and infectious disease medical care across 11+ owned centers in the Buenos Aires metropolitan area, serving more than 450,000 patients per year through insurance billing and direct payments.
- Ownership category
- akta.pro rank
Stamboulian industry classification
Industry- Product category
- Preventive Healthcare Services
- NAICS
- Medical Laboratories (621511), Offices of Physicians (62111), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Immunization & Vaccine Clinics (HLAKAGAJ)
- akta.pro secondary industries
- Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), Sexually Transmitted Infections (STI) (HLAKAGAI), Public & Private Vaccine Provider Networks (Clinics/Pharmacies/Physicians) (HLAJAHAB)
Keywords
Where Stamboulian is headquartered
LocationHeadquarters
- HQ city
- Tandil
- HQ country
- Argentina
- HQ region
- Latin America
Offices13 records
Markets served
Stamboulian business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Vaccination Services: Administration of vaccines for children, adolescents, adults, and seniors across all life stages. Includes National Vaccination Calendar vaccines, travel vaccines (yellow fever), dengue vaccine, HPV vaccine, flu vaccine, and specialty vaccines. Revenue generated through direct patient payments and insurance/reimbursement agreements with Obras Sociales and Prepagas.
- Clinical Laboratory Services: Reference laboratory offering diagnostic testing including routine analyses, specialized microbiology, COVID-19 RT-PCR and rapid antigen tests, and HPV molecular detection and genotyping. Revenue generated through medical orders billed to insurance providers and direct patient payments.
- Medical Attention Services: Infectious disease consultations and traveler medicine services. Revenue from patient consultations and insurance billings.
- Food Safety and Environmental Hygiene Services: Audits, training, and laboratory testing for food safety and environmental hygiene for businesses and institutions.
Distribution channels5 records
Marketing channels6 records
Stamboulian product offering
Product offeringCore offering
Stamboulian provides vaccination services (routine, travel, and specialty vaccines), clinical reference laboratory diagnostics, infectious disease medical consultations, and food/environmental safety testing from 11+ centers across Buenos Aires to more than 450,000 patients annually. The company also runs a reference laboratory serving external healthcare professionals and conducts clinical trials for vaccine and pharmaceutical development.
Product overview
Stamboulian Servicios de Salud is a healthcare services company operating as a platform of interconnected medical services centered on infectious disease prevention, diagnosis, and treatment. The core offerings include: (1) Servicio Vacunas - comprehensive vaccination services across multiple locations providing routine immunizations, travel medicine vaccines, and specialized vaccines (dengue, HPV, flu); (2) Servicio Laboratorio - clinical reference laboratory with COVID-19 RT-PCR/rapid antigen testing, HPV molecular detection and genotyping, and general diagnostic testing, complemented by a Planta de Procesamiento for high-volume processing; (3) Atención Médica - general medical consultations including specialized Travel Medicine (Medicina del Viajero) services; (4) Higiene & Seguridad Alimentaria y Ambiental - food safety and environmental health division with audits, training, and microbiological testing; (5) Clinical Trials - clinical research services; and (6) Revista Reflexiones - institutional health education magazine. Supporting patient-facing digital tools include Portal LAB (client results portal), vaccine and laboratory study search tools, and online medical order submission. The company also maintains reference laboratory operations for healthcare professional referrals.
Differentiator
Problem solved
Functional benefit
Products and services
- Servicio Vacunas (Vaccination Service) Comprehensive vaccination service providing immunizations across all life stages including routine National Immunization Calendar vaccines, recommended adult schedules, travel vaccines (including yellow fever certificate), and specialty vaccines such as dengue, HPV, and seasonal flu. Services are available without prior appointment at multiple owned centers across Buenos Aires.
- Servicio Laboratorio (Clinical Laboratory Service) Clinical reference laboratory offering diagnostic testing including COVID-19 RT-PCR and rapid antigen tests, HPV detection and genotyping by molecular methods, and general clinical laboratory studies. Includes quality assurance programs and biochemical advisory services for healthcare professionals.
- Atención Médica (Medical Attention Service) Medical consultation services providing general medical care and specialized travel medicine consultations (Medicina del Viajero) for pre-trip health preparation, including required vaccinations for international travel and destination-specific health guidance.
- Higiene y Seguridad Alimentaria y Ambiental (Food and Environmental Safety) Food and environmental safety division offering audits, training, consulting services, and laboratory testing including microbiological testing of food, environmental microbiological assays, and other specialized testing for industrial and commercial clients.
- Laboratorio de Referencia (Reference Laboratory) Reference laboratory with processing plant serving healthcare professionals and institutions requiring specialized diagnostic testing, biochemical advisory services, and client referral programs through a dedicated Portal LAB client portal.
- Clinical Trials Clinical research services conducting clinical trials for vaccine and pharmaceutical development, providing study management and regulatory compliance for medical research sponsors.
- Servicio de Andrología (Andrology Service) Appointment-based andrology service launched at the Barrio Norte French location (French 3085), addressing men's reproductive and urological health.
Quantifiable outcome
- Decrease in hepatitis A cases and elimination of liver transplants due to hepatitis A since vaccine introduction in 2005
- +2 more outcomes
Companies that use Stamboulian
Customer profileSegments6 records
Ideal customer profiles5 records
Stamboulian technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Stamboulian partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Stamboulian competitors and assessment
Company assessmentDirect peers
- Labmedicina: Argentine clinical laboratory network offering diagnostic testing including molecular diagnostics and serving both consumers and physician referrals. Closely comparable to Stamboulian's reference laboratory business model in the Argentine market.
- Previvax: Argentine private vaccination center network offering travel vaccines (including yellow fever certificates), HPV, and routine immunizations. Direct peer to Stamboulian's vaccination services, particularly the travel-medicine and certificate-issuing offerings.
- Diagnóstico Maipú: Argentine diagnostic imaging and laboratory network that explicitly partnered with Stamboulian at the Villa Urquiza center in 2015. Direct peer in reference laboratory and diagnostic services to patients in Buenos Aires, with overlapping physician-referral relationships.
- Vacunar: Argentina's largest private vaccination chain, operating multiple walk-in centers across Buenos Aires and other provinces. The most directly comparable peer to Stamboulian's vaccination services business, with similar walk-in convenience model and broad vaccine portfolio.
Broad incumbents
- CEMIC: Buenos Aires-based academic medical center offering outpatient consultations, vaccination, and diagnostic laboratory services. Comparable to Stamboulian in serving preventive-care patients in AMBA, but with a stronger academic and inpatient orientation.
- Hospital Italiano de Buenos Aires: Major private hospital and outpatient network in Buenos Aires with its own vaccination center, clinical laboratory, and travel medicine clinic. Comparable to Stamboulian's combination of vaccination, laboratory, and infectious-disease consultation services, but anchored in a broader hospital system.
- Swiss Medical Group: One of Argentina's largest private healthcare groups, operating a broad network of medical centers, vaccination services, and diagnostic laboratories. Comparable to Stamboulian as a vertically integrated preventive-care and diagnostics platform serving the Buenos Aires market, but with significantly larger scale and broader service scope.
- OSDE: Argentina's largest private health plan (Prepaga) with its own affiliated clinic, vaccination, and diagnostic network. Comparable to Stamboulian in providing vaccination and laboratory services to Buenos Aires consumers, but operating primarily through captive plan members rather than walk-in retail.
- Galeno: Large Argentine health plan (Prepaga) with affiliated medical centers, vaccination services, and diagnostic laboratories. Comparable to Stamboulian in serving Buenos Aires preventive-care demand, though primarily through plan-member captive channels.
Regional players
- DASA (Diagnósticos da América): Brazil's largest diagnostic and preventive medicine network, operating clinical laboratories and vaccination services. Comparable to Stamboulian as a Latin American reference laboratory and vaccination platform, though scaled to the Brazilian market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Stamboulian compliance and trust
Trust signalCompliance1 record
Stamboulian financial estimates
Financial estimateRevenue estimate
Valuation estimate
Stamboulian leadership team
Management profileNumber of profiles
Profiles5 records
Stamboulian funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Stamboulian M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Stamboulian
What does Stamboulian do?
Stamboulian provides vaccination services (routine, travel, and specialty vaccines), clinical reference laboratory diagnostics, infectious disease medical consultations, and food/environmental safety testing from 11+ centers across Buenos Aires to more than 450,000 patients annually. The company also runs a reference laboratory serving external healthcare professionals and conducts clinical trials for vaccine and pharmaceutical development.
Is Stamboulian a public or private company?
Stamboulian is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Stamboulian founded?
Stamboulian was founded in 1981. It employs 251 to 500 people.
Where is Stamboulian based?
Stamboulian is headquartered in Tandil, Argentina, in the Latin America region.
How does Stamboulian make money?
Four revenue lines are on record. Vaccination Services are the primary driver. The others are clinical Laboratory Services, medical Attention Services and food Safety and Environmental Hygiene Services.
Who are Stamboulian's main competitors?
Direct peers on record are Labmedicina, Previvax, Diagnóstico Maipú and Vacunar. Broad incumbents are CEMIC, Hospital Italiano de Buenos Aires, Swiss Medical Group, OSDE and Galeno. DASA (Diagnósticos da América) is listed as a regional player.
Does Stamboulian have an API?
No public API is recorded for Stamboulian.
What industry is Stamboulian in?
Stamboulian's product category is Preventive Healthcare Services. Its primary akta.pro industry code is HLAKAGAJ, Immunization & Vaccine Clinics, with a secondary code of HLAJAIAD, Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza). Its NAICS code is 621511 and its SIC code is 8071.